|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 31/7068 | (2006.01) |
| A61K 31/70 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1711188 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05712714.4 |
| Date of filing the European patent application | 2005-02-04 | |
| (97) | Date of publication of the European application | 2006-10-18 |
| (45) | Date of publication and mention of the grant of the patent | 2012-06-06 |
| (46) | Date of publication of the claims translation | 2012-11-26 |
| (86) | Number | PCT/US2005/003370 |
| Date | 2005-02-04 |
| (87) | Number | WO 2005/076888 |
| Date | 2005-08-25 |
| (30) | Number | Date | Country code |
| 542494 P | 2004-02-06 | US |
| (72) |
TIDMARSH, George, US
|
| (73) |
Threshold Pharmaceuticals, Inc.,
1300 Seaport Boulevard, 5th Floor, Redwood City, CA 94063,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Priešvėžinė terapija |
| ANTI-CANCER THERAPIES |
| Payment date | Validity (years) | Amount | |
| 2023-12-22 | 347.00 EUR |